focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 23.25
Bid: 22.50
Ask: 24.00
Change: 0.00 (0.00%)
Spread: 1.50 (6.667%)
Open: 24.25
High: 24.50
Low: 22.75
Prev. Close: 23.25
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Angle hails study find; Eqtec buys plant in France

Wed, 20th Jul 2022 20:50

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

UK Oil & Gas PLC - exploration and production company focused on UK and Turkey - Says it will need to seek further finance before the middle of the fourth quarter to fund oil exploration in Turkey. The UK energy company says the operator of the Resan licence intends to shoot a new, unbudgeted seismic programme before continuing with the Basur appraisal drilling program. This, combined with a longer than expected seismic acquisition period, has required additional working capital and deferred the start of cash flows from a successful Basur well, UKOG explains. "Given the promising positive outlook derived from the company's Basur Phase 1 seismic programme, plus the confirmation from the oil seep that the area has an active light oil petroleum system, the company's focus for the forthcoming 6-9 months will be firmly upon the delivery of Phase 2 seismic and a new Basur appraisal well, now anticipated to be able to add near-term oil production to the company in H1 2023," it says.

----------

Chariot Ltd - Devon, England-based transitional energy firm focused on Africa - Sees material increase in its gas resources offshore Morocco so it can fast track its field development plans for the Anchois gas project. Anchois sees an 81% rise in high confidence 1C contingent resources to 365 billion cubic feet from 201 billion and a 76% rise in 2C contingent resources to 637 billion cubic feet, whilst prospective resources covering three undrilled targets at Anchois have been estimated at some 754 billion cubic feet. The total remaining recoverable resource at Anchois now stands at 1.4 trillion cubic feet.

----------

San Leon Energy PLC - Dublin-based oil & gas exploration company - Signs new USD16.0 million 4-year loan to ELI Malta with 14% coupon. In addition, San Leon subscribes for further 10% of ELI's diluted share capital.

----------

Angle PLC - Surrey, England-based medical diagnostics company - Notes results of a University of Athens study undertaken in early-stage non-small cell lung cancer. Study demonstrates the benefit of analysing epigenetic alterations in circulating tumour cells to assess patient prognosis. The company’s Parsortix technology was used to isolate circulating tumour cells that provide the tell-tale signs of the disease. "We are pleased to report on the use of the Parsortix system for the isolation of CTCs in early-stage NSCLC, showing potential to enable genetic analysis that provides informative prognostic information. This showcases the potential of liquid biopsy, using the Parsortix system, as a promising tool for the assessment of early-stage disease, which is a key priority for healthcare systems world-wide," says Chief Executive Officer Andrew Newland.

----------

Eqtec PLC - Cork, Ireland-based gasification company focused on turning waste into sustainable energy - Says French subsidiary has acquired and intends to upgrade and recommission a 6.5 megawatt electric waste-to-energy gasification plant in Villers-sous-Montrond, France. The plant is expected to generate a revenue of more than EUR10 million a year and construction work is expected to start in the first quarter of 2023. Eqtec said the plant, which has already received an investment of EUR35 million, will be acquired at nominal value, as the recommissioning will require a further investment of EUR30 million.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
4 Jan 2024 12:19

Angle shares soar following "breakthrough" cancer diagnostics results

(Alliance News) - Angle PLC on Thursday said that "breakthrough results" from its latest blood sample cancer trials would allow it to expand its product sales and pharma services.

Read more
4 Jan 2024 12:09

LONDON MARKET MIDDAY: Retailers Next and JD Sports bookend FTSE 100

(Alliance News) - Stock prices in London were slightly higher at midday on Thursday, with the FTSE 100 looking set to snap the two-day losing streak it suffered at the start of the year.

Read more
4 Jan 2024 10:43

AIM WINNERS & LOSERS: Angle soars on clinical tests; Likewise sales up

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more
4 Jan 2024 08:58

LONDON MARKET OPEN: Next leads buoyant FTSE 100 amid services PMIs

(Alliance News) - Stock prices in London opened up on Thursday, amid a slew of services PMI data, including for the UK, while reacting to the latest data from China.

Read more
4 Jan 2024 07:58

Angle receives 'breakthrough results' from DNA molecular analysis

(Sharecast News) - Liquid biopsy company Angle received "breakthrough results" from DNA molecular analysis of cancer patient blood samples on Thursday, sending its shares skywards as a result.

Read more
2 Jan 2024 09:04

Angle locks in $250,000 contract with Eisai

(Sharecast News) - Liquid biopsy company Angle has locked in a $250,000 contract with global pharmaceutical company Eisai to deliver circulating tumour cell analysis in a pilot study.

Read more
2 Jan 2024 08:51

IN BRIEF: Angle teams with Japan's Eisai in breast cancer drug trial

Angle PLC - Surrey, England-based medical diagnostics - Signs contract with Eisai Inc, part of Tokyo-based pharmaceutical firm Eisai Co Ltd. Under the agreement, the two will engage in a pilot study worth USD250,000 to Angle. Angle will provide circulating-tumour-cells analysis using its Portrait HER2 assay to assess the response of breast cancer patients to Eisai's BB-1701 antibody-drug conjugate. BB-1701 targets HER2, a protein that speeds up the growth of breast cancer cells. Success in the phase two pilot study will offer the possibility for multiple follow-up studies.

Read more
11 Dec 2023 20:44

TRADING UPDATES: Ondine Biomedical raises GBP2.9 million via placing

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
5 Dec 2023 11:50

IN BRIEF: Angle launches diagnostic kit at cancer symposium

Angle PLC - Surrey, England-based medical diagnostics company - Launches its Portrait Plus CTC staining kit at the San Antonio Breast Cancer Symposium, following "extensive" development, optimisation and validation of the kit. Explains that the kit is read-to-use, and designed for the dentification, characterisation and enumeration of epithelial and mesenchymal cancer cells. This includes those undergoing epithelial-to-mesenchymal transition.

Read more
9 Nov 2023 14:29

Angle says build up of revenue slower than hoped; launches test

(Alliance News) - Angle PLC on Thursday said it expects revenue in 2023 to more than double from 2022 as it announced the launch of a new test aimed to support cancer therapy studies.

Read more
25 Oct 2023 17:28

TRADING UPDATES: Franchise Brands trading in line; Tribe secures loan

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
3 Oct 2023 13:02

Angle hails study which shows Parsortix outperforming lab standard

(Alliance News) - Angle PLC on Tuesday touted the publication of a study by researchers at the University of Tubingen in Germany, which showed that its Parsortix system outperformed the current laboratory standard for disseminated tumour cell harvest.

Read more
14 Sep 2023 09:22

LONDON BROKER RATINGS: JPMorgan ups Rio Tinto; Redburn likes Carnival

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
7 Sep 2023 14:41

EARNINGS UPDATES: Sylvania beats production goal, Angle revenue surges

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on xxxday and not separately reported by Alliance News:

Read more
7 Sep 2023 11:20

AIM WINNERS & LOSERS: CVS plunges on CMA vet probe; Angle ascends

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.